Journal
TRENDS IN CANCER
Volume 4, Issue 8, Pages 553-566Publisher
CELL PRESS
DOI: 10.1016/j.trecan.2018.06.004
Keywords
-
Categories
Funding
- National Institutes of Health [R01CA195077-01A1, R01CA200919-01, 1R01 CA218008-01A1]
- Research Scholar Grant from American Cancer Society [128347-RSG-15-212-01-TBG]
- Elsa U. Pardee Foundationis
Ask authors/readers for more resources
Natural killer (NK) cells of the innate immune system are the first line of defense against infectious agents and cancer cells. However, only a few mechanisms that regulate eradication of tumors by NK cells have been identified. In this review, we present an account of epigenetic mechanisms that modulate the ability of NK cells to eradicate cancer cells. To date, several drugs that target epigenetic modifiers have shown clinical efficacy in cancer. Therefore, once a given epigenetic modifier is validated as a regulator of NK cell function, it can be targeted for NK cell-based cancer immunotherapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available